The Optimal Duration of Adjuvant Endocrine Therapy for Early Stage Breast Cancer—With What Drugs and for How Long?
出版年份 2014 全文链接
标题
The Optimal Duration of Adjuvant Endocrine Therapy for Early Stage Breast Cancer—With What Drugs and for How Long?
作者
关键词
Tamoxifen, Aromatase inhibitor, HR-positive breast cancer, Extended adjuvant therapy, Risk of recurrence
出版物
Current Oncology Reports
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2014-01-03
DOI
10.1007/s11912-013-0358-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Long term results of the Italian Tamoxifen Anastrozole trial
- (2013) F. Boccardo et al. EUROPEAN JOURNAL OF CANCER
- Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs
- (2013) Geniey Yang et al. PHARMACOLOGY & THERAPEUTICS
- Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group
- (2012) Peter C. Dubsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2012) James L. Khatcheressian et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study
- (2011) Judith M. Bliss et al. JOURNAL OF CLINICAL ONCOLOGY
- Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover
- (2011) Huan Jin et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
- (2011) Cornelis JH van de Velde et al. LANCET
- The 2011 EBCTCG polychemotherapy overview
- (2011) Carlo Palmieri et al. LANCET
- Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
- (2011) Meredith M Regan et al. LANCET ONCOLOGY
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism
- (2009) Rohini K. Hernandez et al. CANCER
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction
- (2009) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
- (2008) James J. Dignam et al. BREAST CANCER RESEARCH AND TREATMENT
- Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen
- (2008) Paul E. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial
- (2008) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Systemic Adjuvant Treatment on Risk for Contralateral Breast Cancer in the Women's Environment, Cancer and Radiation Epidemiology Study
- (2007) Lisbeth Bertelsen et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now